(See CV for a full list of publications and abstracts)
Wolfe F, Michaud K. Heart Failure in Rheumatoid Arthritis:
Rates, Predictors, and the Effect of Anti–Tumor Necrosis Factor Therapy
Am J Med.; 2004; 116: 305-311.
Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis Infection in
Patients with Rheumatoid Arthritis and the Effect of Infliximab Therapy.
Arthritis Rheum. 2004; 2: 372–379.
Michaud K, Wolfe F. Congestive Heart Failure in Rheumatoid Arthritis:
Rates, Predictors and the Effect of Anti-TNF Therapy. Am J Med.; 2004
(in press).
Wolfe, F. The Use of Self-Report Questionnaires in the Clinical Care
of Patients With Rheumatoid Arthritis. Chapter, Textbook of Rheumatology.
In Press 2004.
Michaud K, Messer J, Choi HK, Wolfe F. Direct Medical Costs and Their
Predictors in Persons with Rheumatoid Arthritis: a 3-Year Study of 7,527
Patients. Arthritis
Rheum 2003; 48: 2750-2763.
Wolfe
F, Michaud K, Stephenson B, Doyle J. Toward a definition and method
of assessment of treatment failure: the case of leflunomide versus methotrexate.
J Rheumatol
2003;30:1725–32.
Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular
disease prevalence in rheumatoid arthritis. J Rheumatol 2003; 30(1):36-40.
Wolfe F, Pincus T, Thompson A, Doyle J. The assessment of rheumatoid
arthritis and the acceptability of self-report questionnaires in clinical
practice. Arthritis Rheum. 2003; 49: 59-63.
Wolfe, F: Stop Using the American
College of Rheumatology Criteria in the Clinic (Editorial) J
Rheumatol 2003;30:1671-1672.
Wolfe F. Pain Extent and Diagnosis: Development and Validation of the
Regional Pain Scale (RPS) in 12,799 Rheumatic Disease Patients. J
Rheumatol 2003; 30: 369-378.
Wolfe F, Lane NE. The long-term outcome of osteoarthritis: rates and
predictors of joint space narrowing in symptomatic patients with knee
osteoarthritis. J Rheumatol 2002; 29(1):139-146.
Wolfe F, Flowers N, Burke TA, Arguelles LM, Pettitt D. Increase in lifetime
adverse drug reactions, service utilization, and disease severity among
patients who will start COX-2 specific inhibitors: quantitative assessment
of channeling bias and confounding by indication in 6689 patients with
rheumatoid arthritis and osteoarthritis. J Rheumatol 2002; 29(5):1015-1022.
Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D. Gastroprotective
therapy and risk of gastrointestinal ulcers: risk reduction by COX-2
therapy. J Rheumatol 2002; 29(3):467-473.
Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I et al.
Evidence from clinical trials and long-term observational studies that
disease-modifying anti-rheumatic drugs slow radiographic progression
in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford)
2002; 41(12):1346-1356.
Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T et al. HLA-DRB1
genotype associations in 793 white patients from a rheumatoid arthritis
inception cohort: frequency, severity, and treatment bias. Arthritis
Rheum 2002; 46(9):2320-2329.
Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. The effect of health
related quality of life on reported use of health care resources in
patients with osteoarthritis and rheumatoid arthritis: a longitudinal
analysis. J Rheumatol 2002; 29(6):1147-1155.
Choi HK, Michaud K, Wolfe F. Utility measures in rheumatic diseases.
Arthritis Rheum (suppl) 2002; 46(9).
Wolfe F. The determination and measurement of functional disability
in rheumatoid arthritis. Arthritis Res 2002; 4 Suppl 2:S11-S15
H. K. Choi, M. A. Hernan, J. D. Seeger, and F. Wolfe. Methotrexate therapy
and mortality with rheumatoid arthritis. Lancet 359: 1173-1177,
2002.
J Duryea, S. Zaim, F Wolfe. Neural network based automated algorithm
to identify joint locations on hand/wrist radiographs for arthritis
assessments. Med.Phys. 29 (3), March 2002, 403-411.
Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ et al.
A functional promoter polymorphism in the macrophage migration inhibitory
factor (MIF) gene associated with disease severity in rheumatoid arthritis.
Genes Immun 2002; 3(3):170-176.
F. Wolfe. Wolfe F. The psychometrics of functional status questionnaires:
room for improvement. J Rheumatol 2002; 29(5):865-868.
F. Wolfe and H.K. Choi, Benchmarking and the percentile assessment of
RA: adding a new dimension to rheumatic disease measurement. Ann Rheum
Dis 2001;60:994–996.
T. Pincus and F. Wolfe. An infrastructure of patient questionnaires
at each rheumatology visit: Improving efficiency and documenting care.
J.Rheumatol. 27(12): 2727-2730, 2000.
D. A. Albert, S. Aksentijevich, S. Hurst, J. F. Fries, and F. Wolfe.
Modeling therapeutic strategies in rheumatoid arthritis: Use of decision
analysis and Markov models. J Rheumatol 27(3):644-652, 2000.
F. Wolfe, T. Pincus, and J. F. Fries. Usefulness of the HAQ in the clinic.
Ann Rheum Dis 2001; 60: 811.
T. Pincus, G. G. Koch, T. Sokka, J. Lefkowith, F. Wolfe, J. M. Jordan,
G. Luta, L. F. Callahan, X. Wang, T. Schwartz, S. B. Abramson, J. R.
Caldwell, R. A. Harrell, J. M. Kremer, R. L. Lautzenheiser, J. A. Markenson,
T. J. Schnitzer, A. Weaver, P. Cummins, A. Wilson, S. Morant, and J.
Fort. A randomized, double-blind, crossover clinical trial of diclofenac
plus misoprostol versus acetaminophen in patients with osteoarthritis
of the hip or knee. Arthritis Rheum 44 (7):1587-1598, 2001
F. Wolfe and V. Strand. Radiography of rheumatoid arthritis in the time
of increasing drug effectiveness. Curr.Rheumatol Reports
3(1):46-52, 2001.
F. Wolfe, J. R. O'Dell, A. Kavanaugh, K. Wilske, and T. Pincus. Evaluating
severity and status in rheumatoid arthritis. J Rheumatol 28 (6):1453-1462,
2001.
F. Wolfe, J. J. Cush, J. R. O'Dell, A. Kavanaugh, J. M. Kremer, N. E.
Lane, L. W. Moreland, H. E. Paulus, T. Pincus, A. S. Russell, and K.
R. Wilskie. Consensus recommendations for the assessment and treatment
of rheumatoid arthritis. J Rheumatol 28 (6):1423-1430, 2001.
F. Wolfe. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ,
a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses
in 2,491 rheumatoid arthritis patients following leflunomide initiation.
J Rheumatol 28 (5):982-989, 2001.
T. Pincus, T. Sokka, and F. Wolfe. Premature mortality in patients with
rheumatoid arthritis: evolving concepts. Arthritis Rheum 44 (6):1234-1236,
2001.
J. M. Berthelot, M. Klarlund, D. McGonagle, H. J. Bernelot-Moens, A.
Calin, B. Harrison, H. R. Schumacher, K. Kaarela, A. A. Drosos, J. L.
Hulsemann, W. H. Koh, Y. T. Konttinen, L. Punzi, K. Tanimoto, H. J.
Williams, F. Wolfe, C. A. Zerbini, and A. Saraux. Lessons from an international
survey of paper cases of 10 real patients from an early arthritis clinic.
CRI (Club Rhumatismes et Inflammation) Group. J Rheumatol 28 (5):975-981,
2001.
Hawley DJ, Wolfe F, Lue FA, Moldofsky H. Seasonal Symptoms and
Seasonal Severity in Patients with Rheumatic diseases: A study of 1,424
patients with up to 24 years symptom follow-up. J Rheumatol 2001;28:1900-9.
Wolfe F, Management of Fibromyalgia [Letter] Ann.Int.Med 2000, 132:
1004.
Wolfe F, The Level of Inflammation in Rheumatoid Arthritis Is Determined
Early and Remains Stable Over the Longterm Course of the Illness. J
Rheumatol 2001;28:1817-24.
Wolfe F. The Importance Of GI Symptom Severity In Rheumatoid And Osteoarthritis:
Symptom Rates And Risk For Gastrointestinal Hospitalization. J Rheumatol.
2000: 1661-1667.
Wolfe F, Hawley DJ. The Comparative Risk and Predictors of Adverse GI
Events in Rheumatoid Arthritis and Osteoarthritis: A Prospective, 13-Year
Study of 2,131 Patients. J Rheumatol. 2000; 27:1668-1674.
Wolfe F, van der Heijde DM, Larsen A. Assessing Radiographic Status
of Rheumatoid Arthritis: Introduction of a Shortened Erosion Scale (SES).
J Rheumatol. 2000: 27:2090-2099. Press).
Wolfe F, Hawley J, Goldenberg DL, Russell IJ, Buskila D, Neuman L. The
Assessment of Functional Impairment in Fibromyalgia: Rasch Analyses
of 5 Functional Scales – FIQ, HAQ, MHAQ, IHAQ, SF-36 – and the Development
of a New Scale, the FHAQ. J.Rheumatol. 27: 1989-1999, 2000.
Smolen,J.S.; Strand,V; Cardiel,M.; Edworthy,S.; Furst,D.; Gladman,D.;
Gordon,C.; Isenberg,D.A.; Klippel,J.H.; Petri,M.; Simon,L.; Tugwell,P.;
Wolfe,F. Randomized clinical trials and longitudinal observational studies
in systemic lupus erythematosus: Consensus on a preliminary core set
of outcome domains. J.Rheumatol. 26:504-507, 1999.
Maini,R.N.; Wolfe,F.: Workshop summary: health outcomes and health economic
issues surrounding the use of biological therapies in patients with
rheumatoid arthritis. Rheumatology 38: 58-49, 1999.
Wolfe F, Kong SX, Watson, DJ: Gastrointestinal Symptoms and Health-Related
Quality of Life in Patients with Arthritis. J.Rheumatol. 2000; 27:1373,1378.
Pincus T, Swearingen C and Wolfe F. Toward a multi-dimensional health
assessment questionnaire (MDHAQ): Assessment of advanced activities
of daily living and psychological status in the patient-friendly health
assessment questionnaire format. Arthritis.Rheum 1999; 42:2220-2230.
Wolfe F, Zhao S and Lane N. Preference for Non-Steroidal Anti-Inflammatory
Drugs (NSAIDs) over Acetaminophen by Rheumatic Disease Patients: A Survey
Of 1799 Patients with Osteoarthritis, Rheumatoid Arthritis and Fibromyalgia.
Arthritis.Rheum 2000; 43:378-385.
Aronoff GM, Markowitz M, Dorto AJ, Ranavaya MI, Talmage JB, Wolfe F,
Andersson G, Cocchiarella L, Harlason III R, Neville Jr CH, et al.
AADEP Position Paper - Fibromyalgia: impairment and disability issues.
American Academy of Disability Examing Physicians 1999;8(3
- Special Pull out section):1-10.
Wolfe, F. Kong, SX: Rasch analysis of the Western Ontario MacMaster
Questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid
arthritis, and fibromyalgia. Ann.Rheum.Dis 1999: 563-568.
Wolfe, F. The effect of smoking on clinical, laboratory and radiographic
status in RA. J.Rheumatol. 27:630-639, 2000.
Wolfe F: Psychological distress and rheumatic disease (Editorial). Scand.
J. Rheumatol. 28:131-136, 1999.
Wolfe F and Skevington S: The Epidemiology of Distress. 2000, J. Rheumatol.
27:2000-2009, 2000.
Buckland-Wright JC, Wolfe F, Ward RJ, Flowers N, Hayne C: Substantial
superiority of semi-flexed (MTP) views in knee osteoarthritis: a comparative
radiographic study, without fluoroscopy, of standing extended, semi-flexed
(MTP) and schuss views. J.Rheumatol. 26:2664-2674, 1999 .
Ehrich E, Levy, R, Zeng, Q, Seidenberg, B., Schnitzler, T, Wolfe F,
Morrison B, Gertz B, Mcilwain H, Weisman M, Bolognese J: Effect of specific
Cox-2 inhibition in osteoarthritis of the knee: a 6-week double blind,
placebo-controlled, pilot study of rofecoxib. J. Rheum. 26:2438-2447,
1999.
F. Wolfe, M. Lassere, D. van der Heijde, G. Stucki, M. Suarez-Almazor,
T. Pincus, K. Eberhardt, T.K. Kvien, D. Symmons, A. Silman, P. van Riel,
P. Tugwell and M. Boers. Preliminary Core Set of Domains and Reporting
Requirements for Longitudinal Observational Studies in Rheumatology.
J.Rheumatol 26:484-489, 1999
Wolfe F and Winfield JB. Fibromyalgia Consensus Report: A few more comments.
J Clin.Rheumatol 1998;4(3):118-9..
Wolfe F. What use are fibromyalgia control points? Dr. Wolfe replies.
J Rheumatol 1998;25(12):2476.
Wolfe F. Critical issues in longitudinal and observational studies including
study purpose, short term versus long term studies, selection of study
instruments, methods of carrying out studies, outcomes to be studied.
J.Rheumatol 26:469-472, 1999.
Wolfe F. and Pincus T. Listening to the Patient: A practical Guide to
Self-report Questionnaires In Clinical Care. Arthritis Rheum. 42:1798-1808
1999.
Wolfe F. and Hawley DJ. Evidence of Disordered Symptom Appraisal in
Fibromyalgia: Increased Rates of Reported Comorbidity and Comorbidity
Severity. Clin.Exp.Rheumatol. 17:297-303, 1999.
Wolfe F. and Hawley DJ. Psychosocial factors and the fibromyalgia syndrome.
Zeitschrift fur Rheumatologie (Supp 2) 57: 88-91, 1999.
Wolfe F. “Silicone Related Symptoms” Are Common In Patients with Fibromyalgia:
No Evidence for A New Disease. J.Rheumatol 26: 1172-1175 1999.
Wolfe F. and Anderson J. Silicone breast implants and the risk of fibromyalgia
and rheumatoid arthritis J.Rheumatol. 26: 2025-2028 1999.
Wolfe F. Determinants of WOMAC function, pain and stiffness scores:
evidence for the role of low back pain, symptom counts, fatigue and
depression in osteoarthritis, rheumatoid arthritis and fibromyalgia.
Rheumatology 38: 355-361,1999.
Wolfe F. Fibromyalgia in a grand bio-psycho-social model - Reply. J
Rheumatol 1998;25(5):1029-30.
Wolfe F, Albert DA, and Pincus T. A survey of United States rheumatologists
concerning effectiveness of disease-modifying antirheumatic drugs and
prednisone in the treatment of rheumatoid arthritis. Arthrit.Care Res.
1998;11(5):375-81.
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH,
Heyse SP, Hirsch R, Hochberg MC, Hunder GG et al. Estimates of
the prevalence of arthritis and selected musculoskeletal disorders in
the United States. Arthritis Rheum. 1998;41(5):778-99.
Pincus, T. and Wolfe, F.: “No evidence of disease” in rheumatoid arthritis
using methotrexate in combination with other drugs: a contemporary goal
for rheumatology care? Clin. Exp. Rheum 1997; 15 591-596.
Pincus, JT and Wolfe,F.: Patient Self-report questionnaires as integral
to clinical care. The Behavioral Measurements Letter 5:3-7, 1997.
Wolfe, F. and Sharp. The long-term outcomes of rheumatoid arthritis:
A 23-year prospective, longitudinal study of total joint replacement
and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis
Rheum. 1998;41(6):1072-82.
Wolfe, F. and Hawley. The long-term outcomes of rheumatoid arthritis:
Work disability: A prospective 18 year study of 823 patients. J Rheumatol
1998;25(11):2108-17.
Wolfe, F. and Zwillich, SH. The long-term outcomes of rheumatoid arthritis:
A 23 year prospective, longitudinal study of total joint replacement
and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis.Rheum.
1998; 41: 1072-1082.
Hawley DJ, Wolfe F. Fatigue and musculoskeletal pain. Phys Med Rehab
Clin N A.: 8:101-11, 1997.
Wolfe, F. The Prognosis of Rheumatoid Arthritis: Assessment of Disease
Activity and Disease Severity in the Clinic. Am.J.Med (Suppl), 103:12S-18S.
D. Buskila, L. Neumann, G. Vaisberg, D. Alkalay, F. Wolfe. Increased
rates of fibromyalgia following cervical spine trauma: a controlled
study of 161 cases of traumatic injury. Arthritis.Rheumatism 40:446-452,1997
Frederick Wolfe, Janice Anderson, Deborah Harkness, Robert M. Bennett,
Xavier Caro, Don M. Goldenberg, I. Jon Russell, and Muhammad B. Yunus.
A Prospective, Longitudinal, Multicenter Study of Service Utilization
and Costs in Fibromyalgia. Arthritis.Rheumatism 1997;1571-1579.
Frederick Wolfe, Janice Anderson, Deborah Harkness, Robert M. Bennett,
Xavier Caro, Don M. Goldenberg, I. Jon Russell, and Muhammad B. Yunus.
Health Status and Disease Severity in Fibromyalgia: Results of a Six
Center Longitudinal Study. Arthritis.Rheumatism 1997;1560-1570.
F.Wolfe. The relationship between tender points and fibromyalgia symptom
variables: evidence that fibromyalgia is not a discrete disorder in
the clinic. Ann. Rheum. Dis. 1997;56:269-271.
F.Wolfe. What use are fibromyalgia control points? J.Rheumatol. 1998;25:546-550.
F.Wolfe. The fibromyalgia problem [Editorial]. J.Rheumatol. 1997;24:1247-1249
F. Wolfe. Adverse drug reactions of DMARDS and DC-ARTS in Rheumatoid
Arthritis. Clin.Exp.Rheumatol. 1997:15:S75-S81.
F.Wolfe. The crp but not the esr is associated with clinical severity
in patients osteoarthritis of the knee or hip. J. Rheumatol. 1997;24:1486-1488.
F. Wolfe. A comparison of rheumatoid factor by nephelometry and latex
methods: clinical and laboratory significance. Arthritis Care and Research1998;11:89-93.
F. Wolfe. PWCORRS - An enhanced correlation display for Stata. Stata
Technical Bulletin STB-35: 22-24, 1997.
F. Wolfe and D.J. Hawley. Measurement of the quality of life in rheumatic
disorders using the EuroQol. Brit.J.Rheumatology, 1997;36:786-793.
F. Wolfe. The comparative usefulness of the C-reactive protein and the
erythrocyte sedimentation rate in patients with rheumatoid arthritis.
J.Rheumatol, 1997;24:1477-1485
McDermott M, Kastner DL, Holloman JD, et al. The role of T cell receptor
beta chain genes in susceptibility to rheumatoid arthritis. Arthritis
Rheum. 1995;38:91-5.
Felson DT, Anderson JJ, Boers M, et al. American college of rheumatology
preliminary definition of improvement in rheumatoid arthritis. Arthritis
Rheum. 1995;38:727-35.
Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol. 1996;23:13-22.
Wolfe F, Anderson J, Harkness D, et al. The Work and Disability Status
of Persons With Fibromyalgia. 1997;25:1171-1178.
Williams CA, Bloch DA, Sibley J, et al. Lymphoma and leukemia in rheumatoid
arthritis: are they associated with azathioprine, cyclophosphamide,
or methotrexate? A matched case-control study in the Arthritis, Rheumatism
and Aging Medical Information System (ARAMIS) population. J Clin Rheumatol.
1996;2:64-72.
Plesh O, Wolfe F, Lane NE. The Prevalence of Fibromyalgia and Temporomandibular
Disorders (TMD) in Patients. J Rheumatol. 23: 1948-1952, 1996
Wolfe F. Fibromyalgia and Myofascial Pain Syndrome. In Pain management:
theory and practice. Edited Portenoy, RK and Kanner, RM. Chapter 7,
pp 145-169, 1996, F.A. Davis Co, Philadelphia, PA.
Altman, RD, Hochberg M, Murphy Jr., WA, Wolfe F and Lequesne M.: Atlas
of individual radiographic features in osteoarthritis. Osteoarthritis
and Cartilage 1995; 3: 3-70.
Wolfe F, Potter JW. Fibromyalgia and work disability: is fibromyalgia
a disabling disorder? Rheum Dis Clin N Amer. 1996;22:369-92.
Mata S, Wolfe F, Lawrence J, Esdaile F. Absence of an association of
RA and DISH: a case control study. J. Rheumatol. 1995.
Wolfe F: The epidemiology of drug treatment failure in rheumatoid arthritis.
Bailliares Clinical Rheumatology 1995;9: 619-632
Wolfe F and the Vancouver Fibromyalgia Consensus Group. The fibromyalgia
syndrome: a consensus report on fibromyalgia and disability. J. Rheumatology
1996; 23: 534-539.
Wolfe F, Aarflot T, Bruusgaard D, Henriksson KG, Littlejohn G, Moldofsky,
H, Raspe HH, Vaeroy H: Fibromyalgia and Disability. Report of the Moss
working group on medical-legal aspects of chronic widespread pain complaints
and fibromyalgia. Scand J Rheumatol 1995; 24: 112-8.
Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels,
pain threshold and fibromyalgia symptoms in the general population.
J. Rheumatol 24: 555-559, 1997.
Wolfe F, Wilson K, Anderson J, Hawley DJ: The prevalence and meaning
of fatigue in rheumatic disease. J. Rheumatol. 1996; 23:1407-1417.
Wolfe F; Hawley DJ; Peloso PM; Wilson K; Anderson J, P: Back pain in
osteoarthritis of the knee. Arthritis Care Res 1996 Oct;9(5):376-83
Peloso, P, Wolfe F, Hawley DJ: Back Pain in Rheumatoid Arthritis. Submitted.
Wolfe F and Pincus T: A Data Base for Rheumatoid Arthritis. Rheumatic
Disease Clinics of North America. 1995;21:481-500.
Wolfe F and Pincus T: Health Status Questionnaires. Rheumatic Disease
Clinics of North America. 1995;21:445-464.
Wolfe F and Pincus T: Data Collection in the clinic. Rheumatic Disease
Clinics of North America 1995;21:321-358.
Wolfe, F: Fibromyalgia: in Anesthesia: biologic foundations, Edited
by Biebuyck J, Lynch C, Maze M, Saidman LJ, Yaksh TL and Zapol W. Lippincott-Raven
1997, 905-920.
Wolfe F, Weinblatt ME, Kaplan H, Germain BF, et al.: Methotrexate in
rheumatoid arthritis - A five-year prospective multicenter study. Arthritis
Rheum 1994; 37:1492-1498.
Wolfe F, Pincus T, Callahan LF: Introduction. Rheumatoid Arthritis:
Pathogenesis, Assessment Outcome and Treatment. New York: Marcel Dekker,
1994; -74.
Wolfe F: Aspects of the epidemiology of fibromyalgia. J.Musc.Pain 1994;2:65-74.
Felson D, Anderson J, Boers M, Bombardier C, Chernoff M, Fried B, Furst
D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt
M, Widmark R, Williams J, Wolfe F: Reduced joint counts in rheumatoid
arthritis clinical trials. Arthritis Rheum 1994; 37:463-464.
Wolfe F, Michaud K: The clinical and research significance of the erythrocyte
sedimentation rate. J Rheumatol 1994; 21:1227-1237.
Wolfe F: Data collection and utilization: a methodology for clinical
practice and clinical research. In: Wolfe F and Pincus T, eds.: Prognosis
and Treatment of Rheumatoid Arthritis. New York: Marcel Dekker, 1994:463-514.
Wolfe F: Interrater reliability of the tender point criterion for fibromyalgia
(Letter). J Rheumatol 1994; 21:370.
Wolfe F: On criteria and classification. J.Mus.Pain 1994; 2:21-37.
Wolfe F: Post-traumatic fibromyalgia: a case report narrated by the
patient. Arthritis Care Res; 7:161-165,1994.
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and
characteristics of fibromyalgia in the general population. Arthritis
Rheum 1995;38:19-28.
Wolfe F, Hawley DJ: Fibromyalgia in the adult Danish Population (Letter).
Scand J Rheumatol 1994; 23:55.
Wolfe F, Hawley DJ, Ross K, Anderson J: The increase in depression rates
and scores in clinic patients with rheumatoid arthritis, osteoarthritis,
and fibromyalgia compared to persons in the general population. 1994
(UnPub).
Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia on
the general population: sex, pain threshold and fibromyalgia symptoms.
J. Rheumatol 1995; 22:151-156.
Hawley DJ, Wolfe F: Effect of light and season on pain and depression
in subjects with rheumatic disorders. Pain 1994; 59:227-234.
Wolfe F, Cathey MA, Hawley DJ: A double-blind placebo controlled trial
of fluoxetine in fibromyalgia. Scand. J. Rheum 1994; 23: 255-259.
Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz
PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis.
Arthritis Rheum 1994; 37:481-494.
Wolfe F: When to diagnosis fibromyalgia. Rheum Dis Clin North
Am, 1994; 20: 485-501.
Sharp J, Wolfe F, Corbett M, Isomaki H, Mitchell D, Furst D, Sibley
J, Shipley M: Radiological progression in rheumatoid arthritis -How
many patients are required in a treatment trial to test disease modification?
Ann Rheum Dis 1993, 52:332-337.
Strand V, Lipsky P, Cannon G, Calabrese L, Wiesenhutter C, Cohen
S, Olsen N, Lee M, Lorenz T, Nelson B, Cush J, Wolfe F, Fleischmann
R, Karr R, Krick G, Medsger T, Rigby W, Fox D,Swartz T, Multz C, Weisman
M: CD5 Plus RA Investigators Group: "Effects of administration
of an anti-CD5 immunoconjugate in rheumatoid arthritis: Results of two
Phase II studies. Arthritis Rheum 1993; 36:620-630.
Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA: The prognosis of
rheumatoid arthritis and undifferentiated polyarthritis syndrome clinic:
A study of 1141 patients. J Rheumatol 1993; 20:2005-2009.
Wolfe F and Hawley DJ: The relationship between clinical activity and
depression on rheumatoid arthritis. J Rheumatol 1993; 20:2032-2037.
Wolfe F. Fibromyalgia and problems in classification of musculoskeletal
disorders. In: Vaeroy H and Merskey H, eds. Progress in fibromyalgia
and myofascial pain. Amsterdam:Elsevier Science Publishers B.V., 1993:217-235.
Wolfe F. Fibromyalgia and Myofascial Pain Syndrome. In: Portnoy R, ed.
1993:
Michel BA, Bloch DA, Wolfe F, Fries J: Fractures in Rheumatoid Arthritis
- An Evaluation of Associated Risk Factors. J Rheumatol 1993, 20:1666-1669.
Parker, JC, Bradley LA, DeVellis RN, Gerber LH, Holman HR, Keefe FJ,
Lawrence TS, Liang MH, Lorig KR, Nicassio PM, Revenson TA, Rogers MP,
Wallston KA, Wilson MG, Wolfe F: Biopsychosocial contributions
to the management of arthritis disability: Blueprints from an NIDRR-sponsored
conference. Arthritis Rheum 1993; 36:885-889.
Wolfe F and Hawley DJ. Fibromyalgia. In: Kelley WN, Harris EDJ, Ruddy
S, Sledge CB, eds. Textbook of Rheumatology (Supplement). 1993:
Cannon GW, Emkey RD, Denes A, et al: Prospective 5-year follow-up of
recombinant interferon-g in rheumatoid arthritis. J Rheumatol 1993;
20:1867-1873.
Wolfe F: Clinical, laboratory, and radiographic assessments. Curr Opinion
in Rheum 1993; 5:138-145.
Wolfe F: The Epidemiology of fibromyalgia. J Musculo Med 1993;
1:137-148.
Wolfe F: On Diagnosis and Certainty. J Musc Pain 1993; 1:17-36.
Wolfe F: Fibromyalgia and related disorders. In Advances in Neurology.
(In Press 1992).
Hawley DJ, Wolfe F.: Depression is not more common in rheumatoid arthritis:
a ten year longitudinial study of 6,608 patients. J Rheumatol 1993;
20:2025-2031.
Wolfe F, Hawley DJ, Cathey M.A.: Measurement of gold treatment effect
in clinical practice: Evidence for the efficacy of intramuscular gold
therapy. J Rheumatol 1993; 20:797-802.
Wolfe F: Hugh A Smythe. J Musc Pain 1993; 1:13-16.
Wolfe F: The curious case of intramuscular gold. Rheum Dis Clin
North Am 1993, 19:173-188.
Bennett, RM, Smythe, HA, and Wolfe, F: Recognizing Fibromyalgia. Patient
Care 26:211-228, 1992.
Wolfe F: Disability and the Dimensions of Distress in Fibromyalgia.
J Musculo Pain 1993; 1:65-88.
Parker JC, Bradley LA, DeVellis RM, Gerber LH, Holman HR, Keefe FJ,
Lawrence TS, Liang MH Lorig KR, Nicassio PM, Revenson TA, Rogers MP,
Wallston KA, Wilson MG, Wolfe F: Biopsychosocial contributions to the
management of arthritis disability: Proceedings from an NIDRR-sponsored
conference. Arthritis Rheum 1993; 52:332-337.
Felson D, Anderson J, Boers M, Bombardier C, Chernoff M, Fried B, Furst
D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt
M, Widmark R, Williams J, Wolfe F: American College of Rheumatology
Core Set of Disease Activity Measures for Use in Rheumatoid Arthritis
Clinical Trials. Arthritis Rheum 1993; 36:729-740.
Hochberg MC, Chang R, Dwosh I, Lindsey S, Pincus T, Wolfe F: The 1991
American College of Rheumatology revised criteria for the classification
of global functional status in rheumatoid arthritis. Arthritis
Rheum 1992; 35:498-502.
Wolfe, F:. The Use of Classification Criteria in the Diagnosis of Rheumatoid
Arthritis - Comment. Arthritis Rheum 1992; 35:844.
Pincus T and Wolfe F: Gold Therapy for Rheumatoid Arthritis - Response.
Ann Intern Med 1992; 117:170
Wolfe F, Simons DG, Fricton JR, et alThe Fibromyalgia and Myofascial
Pain Syndromes - A Preliminary Study of Tender Points and Trigger Points
in Persons with Fibromyalgia, Myofascial Pain Syndrome and No Disease.
J Rheumatol 1992; 19:944-951.
Hawley DJ and Wolfe F: Sensitivity to change of the Health Assessment
Questionnaire (HAQ) and other health status measures in Rheumatoid Arthritis:
Results of short term clinical trials and observational studies versus
long term observational studies. Arthritis Care Res 1992;5:130-136.
Wolfe F: Inflammatory rheumatic disorders involving the cervical spine.
In Tollison CD,Satterthwaite JR, eds. In Painful Cervical Trauma: Diagnosis
And Rehabilitative Treatment Of Neuromusculoskeletal Injuries, Williams
& Wilkins, Baltimore 1992, 348-361.
Wolfe F: Fibromyalgia and cervical pain: Diagnosis and rehabilitative
treatment of neuromusculoskeletal injuries.In Tollison CD, Satterthwaite
JR, eds.: Painful Cervical Trauma: Diagnosis And Rehabilitative Treatment
Of Neuromusculoskeletal Injuries, Williams & Willkins, Baltimore,
1992, 319-336.
Hawley DJ, Wolfe F, and Cathey MA: The Sense of Coherence Questionnaire
in Patients with Rheumatic Disorders J Rheumatol 1992; 19:1912-1918.
Pincus T and Wolfe F: Treatment of Rheumatoid Arthritis: Challenges
to Traditional Paradigms (Editorial). Ann Int Med 1991;115:825-227.
Hawley DJ and Wolfe F: Pain, Disability, and Pain/Disability Relationships
in Seven Rheumatic Disorders: A study of 1,522 Patients. J Rheumatol
1991;18:1522-1557.
Wolfe F and Cathey MA:The Assessment and Prediction of Functional Disability
in Rheumatoid Arthritis. J Rheumatol 1991; 18:1298-1306.
Wolfe F, Cathey MA, and Roberts FK:The latex test revisited: Rheumatoid
factor testing in 8,287 rheumatic disease patients: Arthritis Rheum
1991;34:951-960.
Wolfe F, Hawley DJ, Cathey MA: Health status measures over time: prognosis
and outcome assessment in rheumatoid arthritis. J.Rheumatol 1991; 18:1290-1297.
Wolfe F: Criteria for Fibromyalgia: The American College of Rheumatology
1990 Criteria for the Classification of Fibromyalgia. In Muller, W.
(Editor), Generalisierte Tendomyopathie (Fibromyalgie). Steinkopf Verlag
Darmstadt, 1991;13-22.
Wolfe F: The epidemiology of NSAID associated Gastrointestinal Disease.
Eur J Rheum Inflamm 1991;11:12-28.
Wolfe F and Cathey MA:The Misdiagnosis of Gout and Hyperuricemia. J
Rheumatol 1991;18:1232-1234.
Wolfe F and Cathey MA: The Effect of Age on Methotrexate Efficacy and
Toxicity. J.Rheumatol 1991; 18:973-977.
Hawley DJ and Wolfe F: Are the results of controlled clinical trials
and observational studies in rheumatoid arthritis valid and generalizable
as measures of rheumatoid arthritis outcome: An analysis of 122 studies.
J.Rheumatol 1991;18:1008-1014.
Wolfe F and Pincus T: Standard self?report questionnaires in routine
clinical and research practice - An opportunity for patients and rheumatologists.
J Rheumatol 1991;18: 643-646.
Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B,
Anderson L, Block S, Small R, Wolfe F, Gall E, Torretti D, Polisson
R: Methotrexate in rheumatoid arthritis: Effects on disease activity
in a multicenter prospective study. J Rheumatol 1991;18:3, 334-338.
Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K,
Brown C, Cooke T.D., Daniel W, Feldman D, Greenwald R, Hochberg M, Howell
D, Ike R, Kapila P, Kaplan D, Koopman W, Marino C, McDonald E, McShane
D.J.,Medsger T, Michel B, Murphy W.A., Osial T, Ramsey-Goldman R, Rothschild
B, Wolfe F: The American College of Rheumatology Criteria for the Classification
and Reporting of Osteoarthritis of the Hip. Arthritis Rheum 1991; 34,
505-514.
Wolfe F: Gout and Hyeruricemia. Am. Family Practitioner 1991; 43: 2141-2150.
Sharp JT, Wolfe F, Mitchell DM, and Bloch D.: The progression of erosions
and joint space narrowing scores in rheumatoid arthritis during the
first 25 years of disease. Arthritis Rheum 1991; 34: 660-668.
Wolfe F, and Cathey MA: Analysis of Methotrexate Treatment Effect In
A Longtudinal Observational Study: Utility of Cluster Analysis J Rheumatol
1991; 18:672-677.
Hawley DJ, Wolfe F, Cathey MA, and Roberts FK:Marital Status and Demographic
Characteristics of Clinic Patients with Rheumatoid Arthritis, Fibromyalgia,
and Other Rheumatic Disorders:A Study of 7,293 patients. J Rheumatol
1991;18: 654-660.
Wolfe F: Fibromyalgia. In Bellamy N, ed: Prognosis in the rheumatic
diseases. Klewer Academic Publishers, Dordrecht, 1991; 321-332.
Wolfe F: The prognosis of rheumatoid arthritis. In Bellamy N, ed: Prognosis
in the rheumatic diseases; Klewer Academic Publishers, Dordrecht, 1991;
37-82.
Wolfe F: Sleep Disturbance in Fibromyalgia (Reply). 1990;Arthritis.Rheum.
Altman R, Alarcon GS, Appelrouth D, et al.: The American College of
Rheumatology Criteria for the Classification and Reporting of Osteoarthritis
of the Hand. Arthritis Rheum 1990; 33:1601-1610.
Wolfe F: Diagnosis of Fibromyalgia: the new criteria. J Musculo Med
1990; 7, 53-69.
Wolfe F: The Fibromyalgia Syndrome. Arthritis and Rheumatism Primary
Care Review 1990; 2: No.4, 1-8.
Wolfe F: Two Muscle Pain Syndromes: fibromyalgia and the myofascial
pain syndrome. Pain Management 1990;3 153-164.
Wolfe F, Cathey MA: Assessment of functional ability in patients with
fibromyalgia (Letter): Arch Int Med: 1990; 150:460.
Wolfe F, Hawley DJ, and Cathey MA: Termination of slow acting anti?rheumatic
therapy in rheumatoid arthritis: A 14 year prospective evaluation of
1017 consecutive starts. J Rheumatol 1990;17:994-1002.
Pincus T, Olsen NJ, Russell IJ, et al.: Multicenter study of recombinant
human erythropoietin in correction of anemia in rheumatoid arthritis.
Am J Med 1990; 89:161-168.
Wolfe F: 50 years of anti?rheumatic therapy: The prognosis of rheumatoid
arthritis. J Rheumatol 17 (suppl)1990;12: Supp 22:24-32.
Krantz SB, Sawada KI, Wolfe F, Bocagno J: Erythropoietin: Receptors
and clinical use in rheumatoid arthritis. Int J Cell Cloning 1990; 8
Suppl 1:181-95; discus.
Wolfe F:The epidemiology of fibromyalgia.Rheum Dis Clin North Am 1990;
16:681-698.
Cannon GW, Emkey RD, Denes A, Cohen SA, Saway P, Wolfe F, Jaffer AM,
Weaver AL, Cogen L, Gulinello, Kennedy SM, Schindler JD: Prospective
Two Year Follow?up of recombinant interferon?gamma in rheumatoid arthritis.
J Rheumatol 1990;17:304-310.
Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B,
Anderson L, Block S, Irby R, Wolfe F, Gall E, Torretti D, Biundo J,
Small R, Coblyn J, Polisson R: Low-dose methotrexate compared with auranofin
in adult rheumatoid arthritis. Arthritis Rheum 1990;33:330-338.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DM,
Tugwell P, Abeles M, Campbell SM, Clark P, Fam AG, Farber SJ, Fiechtner
JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi
AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American
College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia:
Report of the multicenter criteria committee, Arthritis Rheum 1990;33:160-172.
Wolfe F: Methodologic and statistical problems in the epidemiology of
fibromyalgia. In J.R. Friction, E.A. Ewad, eds.: Myofascial Pain and
Fibromyalgia. Raven Press, 1990;147-163.
Cannon GW, Pincus SH, Emkey RD, Denes A, Cohen SA, Wolfe F, Saway PA,
Jaffer AM, Weaver AL, Cogen L, Schindler JD: Double-blind trial of recombinant
y-Interferon versus placebo in the treatment of rheumatoid arthritis.
Arthritis Rheum 1989; 32:964-973.
Wolfe F: The design of a fibromyalgia criteria study. J Rheumatol 1989
Wolfe F: Fibromyalgia: The clinical syndrome. Rheum Dis Clin North Amer
1989;15:1-19.
Wolfe F: Non-pharmacologic therapy: What works? (Editorial) Arthritis
Care & Res 1:1-3, 1988.
Decker JL, McShane DJ, Wolfe F, et al, (ACR Glossary Committee). Dictionary
of Rheumatic Diseases. Volume III, New York, 1988.
Gao X, Ball EJ, Dombrausky L, Olsen NJ, Pincus T, Khan MA, Wolfe F,
Stastny P: Class II Human leukocyte antigens and T Cell Receptor Polymorphisms
in Patients with Rheumatoid Arthritis. Am J Med 85:14-16, 1988.
Khan MA, Yamashita TS, Reynolds TL, Wolfe F, Khan MK: HLA-DR4 genotype
frequency and gender effect in familial rheumatoid arthritis. Tissue
15770/2166,1988.
Hawley DJ, Wolfe F, Cathey MA: Pain, disability and psychological status:
A 12 month study of severity in fibromyalgia. J Rheumatol 15:1551-1556,
1988.
Cathey MA, Wolfe F, Kleinheksel SM, Miller S, Pitetti KH: Functional
ability and work status in patients with fibromyalgia. Arthritis Care
& Res 1(2):1-15, 1988.
Wolfe F: Age of death of parents of patients with rheumatoid arthritis:
Data from a middle class sample. J Rheumatol 16:735-739,1989.
Wolfe F, Kleinheksel SM, Khan MA: Familial versus sporadic rheumatoid
arthritis: A comparison of the demographic and clinical characteristics
of 860 patients. J Rheumatol 15:400-404, 1988.
Wolfe F: Fibromyalgia in the elderly: differential diagnosis and treatment.
Geriatrics 43:57-68, 1988.
Wolfe F, Kleinheksel S, Cathey MA, Hawley DJ, Spitz PW, Fries JF: The
clinical value of the HAQ disability index in patients with rheumatoid
arthritis. J Rheumatol 15:1480-1488, 1988.
Hawley DJ, Wolfe F: Anxiety and depression in rheumatoid arthritis:
A prospective study of 400 patients. J Rheumatol 15(6):932-941, 1988.
Wolfe F: Fibrositis, Fibromyalgia and Musculoskeletal Disease: The Current
Status of the Fibrositis Syndrome. Arch Phys Med and Rehabil 69:527-531,
1988.
Wolfe F, Kleinheksel SM, Khan MA: Prevalence of familial occurrence
in patients with rheumatoid arthritis. Br J of Rheum 27(S2):150-152,
1988.
Khan MA, Wolfe F, Kleinheksel SM, Molta C: HLA DR4 and B27 in familial
and sporadic rheumatoid arthritis. Scan J of Rheum:16:433-436, 1987.
Altman R, Fries JF, Bloch DA, Carstens J, Cooke D, Genant H, Gofton
P, Groth H, McShane DJ, Murphy WA, Sharp JT, Spitz P, Williams CA, Wolfe
F: Radiographic Assessment of Progression in Osteoarthritis. Arthritis
Rheum 30:1213-1225, 1987.
Pincus T, Callahan LF, Bradley LA, Vaughn WK, Wolfe F: Elevated Minnesota
Multiphasic Personality Inventory (MMPI) hypochondriasis, depression
and hysteria scores in patients with rheumatoid arthritis reflect disease
rather than psychological problems. Arthritis Rheum 29: 1456-1467.1986.
Caro, XJ, Wolfe F, Johnston WH, Smith AL: A controlled and blinded study
of immunoreactant deposition at the dermal-epidermal junction of patients
with primary fibrositis syndrome. J Rheumatol 13:1086-1092, 1986.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Cooke TD,
Christy W, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley
S, McShane DJ, Mankin H, Medgser T, Meenan R, Mikkelsen W, Moskowitz
R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F: Development
of criteria for the classification and reporting of osteoarthritis:
classification of osteoarthritis of the knee. Arthritis Rheum 29: 1039-1049,
1986.
Cathey MA, Kleinheksel S, Hawley D, Wolfe F: Socio -economic impact
of fibrositis. Am J Med:81(3A):78-84, 1986.
Wolfe F: The development of criteria for the diagnosis of fibrositis.
Am J Med: 81(3A):99-104, 1986.
Wolfe F: The clinical syndrome of fibrositis. Am J Med: 81(3A):7-14,
1986.
Wolfe F, Schindler J, Cathey MA, Hawley D, Balser JP, Kennedy S: Clinical
trials with R-IFN-G in rheumatoid arthritis.In:S.Pincus,ed. Biologically
Based Immunomodulators in the Therapy of Rheumatic Diseases.Elisivier,
379-397, 1986.
Fries JF, Spitz PW, Mitchell DM, Roth SH, Wolfe F, Bloch DA: Impact
of specific therapy upon rheumatoid arthritis. Arthritis Rheum 19:620-627,
1986.
Wolfe F, Kleinheksel SM, Spitz PW, Lubeck DP, Fries JF, Young DY, Mitchell
DM, Roth SH: A Multi-Center Study of Hospitalization in Rheumatoid Arthritis:
Effect of Health Care System, Severity, and Regional Difference J Rheumatol:13:277-284.
1986.
Wolfe F, Kleinheksel SM, Spitz PW, Lubeck DP, Fries JF, Young DY, Mitchell
D, Roth S: A Multi-Center Study of Hospitalization in Rheumatoid Arthritis:
Frequency, Medical-Surgical Admissions, and Charges. Arthritis Rheum:
29:614-619, 1986.
Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell D, Roth SH: A Multi-Center
Study of Utilization and Costs in Rheumatoid Arthritis. Arthritis Rheum
29:488-493, 1986.
Wendt RG, Wolfe F, McQueen D, Murphy P, Solomon H, Householder M: Polyarticular
Pigmented Villonodular Synovitis in Children: Evidence for a genetic
contribution. J Rheumatol 13:5 921-926, 1986
Decker JL, McShane DJ, Esdaile JM, Levinson JE, Liang MH, Medsger Jr
TA, Meenan RF, Mills JA, Wolfe F (ACR Glossary Committee): Dictionary
of Rheumatic Diseases Volume II New York, 1985.
Germain BF, Dillard CO, Levi L, Mullen BJ, Rahman MA, Rowe HJ, Wolfe
F: A Placebo-Controlled Study of Diclofenac Sodium for the Treatment
of Osteoarthritis of the Hip and Knee. Curr Ther Res 37:259-268, 1985.
Wolfe F, Hawley DJ, Cathey MA, Caro X, Russell IJ: Fibrositis: Symptom
Frequency and Criteria for Diagnosis. J Rheumatol 12:6 1159-1163, 1985.
Wolfe F, Cathey MA: The Epidemiology of Tender Points: A prospective
study of 1520 patients. J Rheumatol 12:6 1164-1168, 1985.
Wolfe F, Cathey MA, Kleinheksel SM, Amos SP, Hoffman RG, Young DY, Hawley
DJ: Psychological Status in Primary Fibrositis and Fibrositis Associated
with Rheumatoid Arthritis. J Rheumatol 11:500-506, 1984.
Wolfe F: Arthritis and Musculoskeletal Pain. Nursing Clinics of North
America 19:565-574, 1984.
Wolfe F, Sheon RP: The Diagnosis of Fibrositis, Diagnosis, July 1984.
Stone G, Wolfe F: Collateral Ligament Calcification Complicating Amyloidosis
Associated with Reiter's Syndrome. J Rheumatol 11:248-250, 1984.
Wolfe F: Tender Points, Trigger Points, and the Fibrositis Syndrome.
Clin Rheum Prac 2:36-38, 1984.
Decker JL, Esdaile J, Hathaway DE, Levinson JE, Liang MH, McShane DJ,
Medsger TA, Meenan RF, Mills JA, Sharp JT, Tan EM, Wolfe F (ACR Glossary
Committee): American Rheumatism Association Nomenclature and Classification
of Arthritis and Rheumatism (1983). Arthritis Rheum 26:8 1029-1032,
1983.
Decker JL, McShane DJ, Esdaile JM, Hathaway DE, Levinson JE, Liang MH,
Medsger Jr TA, Meenan RF, Mills JA, Roth SH, Wolfe F (ACR Glossary Committee):
Dictionary of the Rheumatic Diseases. Volume I: Signs and Symptoms.
New York, Contact Associates, 1982.
Wolfe F, Cathey M: Prevalence of Primary and Secondary Fibrositis. J
Rheumatol 10:965-968, 1983.
Wolfe F, Schurle DR, Lin JJ, Polland SM, Smith TW, Montgomery-Short
R, James DL: Upper and Lower Airway Disease in Penicillamine Treated
Patients with Rheumatoid Arthritis. J Rheumatol 10:406-410, 1983.
Wolfe F, Cathey M, Kleinheksel S: Lenses and Neck Pain. JAMA 249:1707-1708,
1983.
Wolfe F, Young DY: Rheumatoid Arthritis and Antecedent Tonsillectomy.
J Rheumatol 10:309-321, 1983.
Schumacher RH, Cockburn R, McCracken BE, Wenig P, Wolfe F: Essentials
of a Differential Diagnosis of Rheumatoid Arthritis, Philadelphia, Smith
Kline, 1981.
Hadler Reply
HTML format
Nortin Hadler has been an pretergressive, indefatigable critic of
fibromyalgia since its beginnings. "The longer I live the more I see
that I am never wrong about anything, and that all the pains that
I have so humbly taken to verify my notions have only wasted my time,"
wrote George Bernard Shaw, and so it is with Hadler. The Hadler critique
is, of course, elegant and noble, an ineluctable portent of the common
good that could be ours were it not for our apostasy.
Total
Joint Arthroplasty
The Long Term Outcomes of Rheumatoid Arthritis: A 23 Year Prospective,
Longitudinal Study of Total Joint Replacement and Its Predictors in
1,600 RA patients.
Work
Disability in RA
The Long Term Outcomes of Rheumatoid Arthritis: Work Disability: A
Prospective 18-Year Study Of 823 Patients